Yarrow Bioscience (YARW) Net Cash Flow (2017 - 2026)
Yarrow Bioscience's (YARW) quarterly Net Cash Flow came in at $604000.0 in Q1 2026, down 92.71% YoY from $8.3 million in Q1 2025, and up 109.75% on a QoQ basis from -$6.2 million in Q2 2025.
Yarrow Bioscience (YARW) Net Cash Flow (2017 - 2026) Analysis & Trends
Yarrow Bioscience (YARW) has 10 years of Net Cash Flow data on file, last reported at $604000.0 in Q1 2026.
- Quarterly Net Cash Flow fell 92.71% year-over-year to $604000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (down 70.42% YoY) and the FY2025 annual result came in at $4.1 million, up 138.16% from the prior year.
- Net Cash Flow improved to $604000.0 in Q1 2026, from -$6.2 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $15.2 million in Q4 2023 to a low of -$13.3 million in Q3 2024.
- A 5-year average of -$1.3 million and a median of -$4.6 million in 2022 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow soared 429.68% — and 2024, when it tumbled 1562.59%.
- Tracing YARW's Net Cash Flow over 5 years: stood at -$4.6 million in 2022, then soared by 429.68% to $15.2 million in 2023, then plunged by 76.23% to $3.6 million in 2024, then plunged by 271.83% to -$6.2 million in 2025, then jumped by 109.75% to $604000.0 in 2026.
- The last three Net Cash Flow figures came in at $604000.0 (Q1 2026), -$6.2 million (Q2 2025), and $8.3 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -496,000.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -37.14 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 225.59 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -2.83 Bn |
| 10 | Yarrow Bioscience | 32.54 Mn | 9.62 Mn | - | -1.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.71 Mn |
| Jun 30, 2026 | -1.71 Mn |
| Mar 31, 2026 | 604,000.00 |
| Mar 31, 2026 | 604,000.00 |
| Jun 30, 2025 | -6.20 Mn |
| Jun 30, 2025 | -6.20 Mn |
| Mar 31, 2025 | 8.28 Mn |
| Mar 31, 2025 | 8.28 Mn |
| Dec 31, 2024 | 3.61 Mn |
| Dec 31, 2024 | 3.61 Mn |
| Sep 30, 2024 | -13.34 Mn |
| Sep 30, 2024 | -13.34 Mn |
| Jun 30, 2024 | 10.54 Mn |
| Jun 30, 2024 | 10.54 Mn |
| Mar 31, 2024 | -11.56 Mn |
| Mar 31, 2024 | -11.56 Mn |
| Dec 31, 2023 | 15.17 Mn |
| Dec 31, 2023 | 15.17 Mn |
| Sep 30, 2023 | -5.20 Mn |
| Sep 30, 2023 | -5.20 Mn |